Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial.

Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ

Announcement

You can now add alternative names! Click here to add other names that you've published under.

Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial.

Krown SE, Lee JY, Lin L, Fischl MA, Ambinder R, Von Roenn JH. Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial. J Acquir Immune Defic Syndr. 2006 Feb 01; 41(2):149-53.

View in: PubMed

subject areas

Adult
Aged
AIDS-Related Opportunistic Infections
Antiretroviral Therapy, Highly Active
Antiviral Agents
Drug Administration Schedule
Fatigue
Herpesvirus 8, Human
HIV Protease Inhibitors
Humans
Injections, Subcutaneous
Interferon-alpha
Male
Maximum Tolerated Dose
Middle Aged
Neutropenia
Recombinant Proteins
Remission Induction
Sarcoma, Kaposi
Treatment Outcome
Viral Load

authors with profiles

Jeannette Lee